Leptin by itself doesn't hold promise for weight loss — but a new mouse study suggests it could work in combination with ...

Negotiations over a large health care policy package are heating up as Congress hurtles toward a government funding deadline ...

Eli Lilly said its weight loss drug Zepbound led to 47% greater weight reduction than rival medicine Wegovy, made by Novo ...

The Alliance for Pharmacy Compounding rebutted Novo's FDA petition to bar compounding pharmacies from copying its weight loss ...

Children's Health Defense, a nonprofit that has challenged vaccines, doubled Kennedy's pay rate for a shorter tenure.

Eli Lilly said its drug Zepbound led to greater weight reduction than rival Novo Nordisk's Wegovy in a head-to-head ...

The Supreme Court decision on Tennessee’s ban will have implications not just for trans people, but for state regulation of ...

UnitedHealth Group executives were in New York City on Wednesday for their annual investor conference, which was abruptly canceled.

Good morning! Another health care case comes to the Supreme Court today. See my preview below, and keep an eye out for more coverage later today. STAT's ...

ArrakisTx was formed to create RNA-intercepting drugs to fight cancer. Despite some promising data, CEO @michael_gilman says it will shift targets.

The Medicare Advantage program is expected to cost taxpayers and beneficiaries more than $500 billion this year.

Swedish pharmaceutical company Orexo will no longer pursue an app for treating depression after many years of struggling to ...